MeCP2 Interacts with the Super Elongation Complex to Regulate Transcription.

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Loss-of-function mutations in methyl-CpG binding protein 2 (MeCP2) cause Rett syndrome, a severe neurodevelopmental disorder.
• MeCP2 has been primarily considered a transcriptional repressor, but conflicting data suggest broader regulatory roles.
• The precise molecular mechanisms of MeCP2-mediated gene regulation remain largely elusive.

Purpose of the Study:

• To investigate the molecular mechanisms underlying MeCP2-dependent gene regulation.
• To identify novel MeCP2 interactors and functional partners in gene expression.
• To explore the role of MeCP2 in transcriptional elongation.

Main Methods:

• Utilized a human MECP2 gain-of-function Drosophila model to screen for genetic modifiers.
• Performed co-immunoprecipitation and biochemical assays to assess physical interactions between MeCP2 and the Super Elongation Complex (SEC) in human cells and mouse brain.
• Analyzed MeCP2 and AFF4 binding to target genes in mouse cortex using chromatin immunoprecipitation (ChIP) assays.

Main Results:

• Identified subunits of the Drosophila Super Elongation Complex (SEC) as genetic interactors of MECP2.
• Demonstrated physical interaction between MeCP2 and the SEC scaffold protein AFF4 in human cells and mouse brain.
• Showed that loss of MeCP2 in mouse cortex reduces AFF4 binding on synaptic function genes, correlating with decreased RNA polymerase II occupancy.

Conclusions:

• Reveals a novel mechanism where MeCP2 interacts with the SEC to regulate transcriptional elongation.
• Establishes a direct link between MeCP2, AFF4, and RNA polymerase II activity.
• Provides new insights into the multifaceted role of MeCP2 in gene expression and its implications for neurodevelopmental disorders.